Developing new drugs and medical devices is extremely complex and expensive.
Published in Drugs development & discovery.
Developing new drugs and medical devices is extremely complex and expensive. The most critical process in development is getting regulatory alignment, and ultimately, filing for approval from the FDA. This work is manual, slow, and very costly.
Panacea (YC P26) is solving this by hiring the best FDA regulatory consultants in the industry, and pairing them with their AI platform, to deliver the fastest and lowest-cost pathway to FDA approval.
The founders, Haris Javed-Akhtar, MD and Yaman Ziadeh, have previously built, sold, and deployed clinical AI to remove major bottlenecks at some of the biggest enterprises in health insurance. Now they are doing the same for Life Sciences.
Congrats to the team on the launch!